Stock Events

Stryker 

$337.25
562
+$5.23+1.58% Friday 20:00

統計

當日最高
337.34
當日最低
330.2
52週最高
359.74
52週最低
248.16
成交量
1,007,797
平均成交量
1,023,500
市值
128.48B
市盈率
38.54
股息收益率
0.95%
股息
3.2

即將到來

股息

0.95%股息收益率
10年增長
9.77%
5年增長率
8.43%
3年增長率
7.37%
1年增長率
4.92%

收益

30Apr確認
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2
2.49
2.97
3.46
預期每股收益
2.36
實際每股收益
2.5

人們還關注

此列表基於在 Stock Events 上關注 SYK 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

分析師評級

377.56$平均價格目標
最高估價為 $406。
來自過去 6 個月內的 16 個評級。這不是投資建議。
買入
81%
持有
19%
賣出
0%

關於

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Show more...
首席執行官
Kevin Lobo
員工
52000
國家
US
ISIN
US8636671013
WKN
000864952

上市公司